FDA Investigator Jeremy Beber
Jeremy Beber has conducted inspections on 11 sites in 1 countries as of 10 Jul 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
11
Last Inspection Date:
10 Jul 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Jeremy Beber:
Alexandra B Pitkin,
Alexandria L Capuano,
Allison A Rodriguez,
Anderson,
Andy B Lee,
Anita Narula, PhD,
Anna J Vickrey,
Arsen Karapetyan,
Babajide Michael Osunsanmi,
Benny Y Gong,
Binh T Nguyen,
Caryn M Mcnab,
Cathleen A Carr Sharpe,
Celena Ngo,
Comyar Shoghi,
Crystal Monroy,
David G Whitman,
David H Hsu,
David Y Hernandez,
Davis,
Desiree C Iya,
Dyana K Stone,
Emily M Morrison,
Francisco,
Geoffrey M Leist,
Henry E Carrillo,
Herminio C Francisco,
Jeff M Uriarte,
Jennifer M Gogley,
Jeremy H Nguyen,
Jessica B Clark,
Joey V Quitania,
Jolanna A Norton,
Joseph C Francisco,
Joseph C Yen,
Juanita Banuelos,
Judy C Nepsa,
Ka L Wong,
Katherine E Jacobitz,
Kawshalya Pathiraja,
Kevin T Gerrity,
Kim Lthomas Cruse,
Kimberly M Lichter,
Kirtida Patel,
Lakecha N Lewis,
Leonard H Lavi,
Lester O Boian,
Lilly O Barton,
Linda Thai,
LT Mark A Chen, MPH,
Mark C Saale,
Matthew J Johnson,
Mei Chiung Huang (Jo),
Michael D Garcia,
Michael F Schuette,
Nabeela J Chaudhry,
Patricia F Alberico,
Paul A Bonneau,
Phal K Chhun,
Phillip L Toy,
Rachel C Stanton,
Richard W Tubb,
Romero,
Saied A Asbagh,
Santiago Gallardo Johnson,
Sara Jdent Acosta,
Sarah A Hassas,
Selene T Torres,
Sonya L Karsik, RAC,
Sparky L Bartee,
Sundy V Sedwick,
Theresa Kirkham (NMI),
Thomas R Beilke,
Tracey T Duong,
Tuan D Tran,
Victor H Loo,
Victor Victor,
Virgilio F Pacio, CSO,
Zachary A Bogorad
Jeremy Beber's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2009 | FDA 483 | Pacira Pharmaceuticals, Inc. - Form 483, 2009-07-10 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more